165 related articles for article (PubMed ID: 31810931)
1. Analysis of DNA Damage Responses After Boric Acid-mediated Boron Neutron Capture Therapy in Hepatocellular Carcinoma.
Chen KH; Lai ZY; Li DY; Lin YC; Chou FI; Chuang YJ
Anticancer Res; 2019 Dec; 39(12):6661-6671. PubMed ID: 31810931
[TBL] [Abstract][Full Text] [Related]
2. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Efficacy and Radiobiological Effects of Boric Acid-mediated BNCT in a VX2 Multifocal Liver Tumor-bearing Rabbit Model.
Hung YH; Lin YC; Lin YT; Shih GW; Liao JW; Chen KS; Liu HM; Chen YW; Chuang YJ; Yang CM; Peir JJ; Yang CH; Chou FI
Anticancer Res; 2019 Oct; 39(10):5495-5504. PubMed ID: 31570443
[TBL] [Abstract][Full Text] [Related]
5. Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses.
Huang CY; Lai ZY; Hsu TJ; Chou FI; Liu HM; Chuang YJ
J Hepatocell Carcinoma; 2022; 9():1385-1401. PubMed ID: 36600987
[TBL] [Abstract][Full Text] [Related]
6. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma.
Hung YH; Lin YC; Lin YT; Shih GW; Liao JW; Chen KS; Liu HM; Chen YW; Chuang YJ; Yang CM; Peir JJ; Yang CH; Chou FI
Appl Radiat Isot; 2020 Oct; 164():109254. PubMed ID: 32554126
[TBL] [Abstract][Full Text] [Related]
7. Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells.
Bai YC; Hsia YC; Lin YT; Chen KH; Chou FI; Yang CM; Chuang YJ
Anticancer Res; 2017 Nov; 37(11):6347-6353. PubMed ID: 29061819
[TBL] [Abstract][Full Text] [Related]
8. Valproic Acid Enhances Radiosensitization
Lai ZY; Li DY; Huang CY; Tung KC; Yang CC; Liu HM; Chou FI; Chuang YJ
Anticancer Res; 2022 Jul; 42(7):3413-3426. PubMed ID: 35790248
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.
Rodriguez C; Carpano M; Curotto P; Thorp S; Casal M; Juvenal G; Pisarev M; Dagrosa MA
Radiat Environ Biophys; 2018 May; 57(2):143-152. PubMed ID: 29453554
[TBL] [Abstract][Full Text] [Related]
10. Potential of using boric acid as a boron drug for boron neutron capture therapy for osteosarcoma.
Hsu CF; Lin SY; Peir JJ; Liao JW; Lin YC; Chou FI
Appl Radiat Isot; 2011 Dec; 69(12):1782-5. PubMed ID: 21420871
[TBL] [Abstract][Full Text] [Related]
11. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic and histopathological studies of boric acid-mediated BNCT in hepatic VX2 tumor-bearing rabbits: Specific boron retention and damage in tumor and tumor vessels.
Yang CH; Lin YT; Hung YH; Liao JW; Peir JJ; Liu HM; Lin YL; Liu YM; Chen YW; Chuang KS; Chou FI
Appl Radiat Isot; 2015 Dec; 106():176-80. PubMed ID: 26372198
[TBL] [Abstract][Full Text] [Related]
13. DNA damage and biological responses induced by Boron Neutron Capture Therapy (BNCT).
Kondo N
Enzymes; 2022; 51():65-78. PubMed ID: 36336409
[TBL] [Abstract][Full Text] [Related]
14. Dose-rate effect was observed in T98G glioma cells following BNCT.
Kinashi Y; Okumura K; Kubota Y; Kitajima E; Okayasu R; Ono K; Takahashi S
Appl Radiat Isot; 2014 Jun; 88():81-5. PubMed ID: 24360864
[TBL] [Abstract][Full Text] [Related]
15. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma.
Suzuki M; Sakurai Y; Hagiwara S; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Kudo M; Ono K
Jpn J Clin Oncol; 2007 May; 37(5):376-81. PubMed ID: 17578894
[TBL] [Abstract][Full Text] [Related]
16. DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV.
Kondo N; Sakurai Y; Hirota Y; Tanaka H; Watanabe T; Nakagawa Y; Narabayashi M; Kinashi Y; Miyatake S; Hasegawa M; Suzuki M; Masunaga S; Ohnishi T; Ono K
Radiat Environ Biophys; 2016 Mar; 55(1):89-94. PubMed ID: 26573366
[TBL] [Abstract][Full Text] [Related]
17. DNA double-strand break induction in Ku80-deficient CHO cells following boron neutron capture reaction.
Kinashi Y; Takahashi S; Kashino G; Okayasu R; Masunaga S; Suzuki M; Ono K
Radiat Oncol; 2011 Sep; 6():106. PubMed ID: 21888676
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
[TBL] [Abstract][Full Text] [Related]
19. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
20. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
